Navigation Links
Amgen Submits Application to Expand Indication for XGEVA® (Denosumab) to Prevent or Delay Spread of Prostate Cancer to the Bone
Date:6/27/2011

om those described. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic reports on Form 10- Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of June 27, 2011 and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models.

The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we exp
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Amgen Announces Webcast of 2008 Third Quarter Financial Results
2. Amgens Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
3. Call for Applications: The Amgen Award for Science Teaching Excellence
4. Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York
5. Amgen Positioned to Deliver Attractive Growth Over Next Five Years
6. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
7. Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
8. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
9. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
10. Amgens Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
11. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Calif. , June 3, 2015 The ... life of myeloma patients while working toward prevention and ... Annual International Myeloma Working Group (IMWG) Summit June 8-10 ... 100-plus IMWG members will attend the 2015 Summit, which ... the European Hematology Association (EHA).  The focus of the ...
(Date:6/3/2015)... On April 21, 2015, California Senate Bill ... (11-0) and indicates the legislature's desire to support both individual ... Committee Chairman supports the bill and would like to see ... and would also like to see any new participants be ... List” and timing are extremely important. , To be considered ...
(Date:6/3/2015)... CHICAGO , June 3, 2015 ... CIR), a specialty biopharmaceutical company focused on allergy, today ... Company,s novel immunotherapy candidates targeting house dust mite, grass ... European Academy of Allergy and Clinical Immunology (EAACI) Annual ... on 6-10 June. Sunday, 7 June 2015 ...
(Date:6/3/2015)... Innovative biomass supply chain industry leader, ... sponsorship of the first annual Advanced Bioeconomy Feedstocks ... Hotel in New Orleans, June 9-10, the conference brings ... to further the advancements of feedstock by discussing pressing ... logistics, yield improvement and more. , As ...
Breaking Biology Technology:International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 2International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 3International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 4Bmark Energy Announces the Sign-up Deadline for Companies Interested in California’s Direct Access Program is June 12th, 2015 at 5:00pm. 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 3Genera to Sponsor Advanced Bioeconomy Feedstocks Conference 2015 2Genera to Sponsor Advanced Bioeconomy Feedstocks Conference 2015 3
... Orleans and Biloxi by Hurricane Katrina has released another type ... making deadly weather even deadlier. The debate wont help last ... prepare us for tomorrows hurricanes. , ,About a month before ... climate researcher at the Massachusetts Institute of Technology published a ...
... - When you don't use or refrigerate your dairy products, ... stem cells may have the same problem. Except instead of ... new study in the magazine Nature Genetics ... few cell types that self-renew, show deviations in their genetic ...
... Waukesha, Wis. -- DSC Logistics has selected ... Management system to improve productivity and customer service ... DCS Logistics , with corporate offices in ... solution at all of its logistics centers. ...
Cached Biology Technology:In the wake of Katrina, more questions than answers about global climate change 2In the wake of Katrina, more questions than answers about global climate change 3New study reveals potential instability in stem cells 2New study reveals potential instability in stem cells 3
(Date:5/21/2015)... 21, 2015 The Sync Project™ , ... for health, today announced a collaborative partnership with ... will center on collaboration on original research, joint course ... in the collaboration, The Sync Project and BerkleeICE are ... Medicine" in the 2015-2016 academic year.  ...
(Date:5/19/2015)... YORK , May 19, 2015  Technology is ... both internally and in the cloud. Passwords and their ... use of OTP and standards-based specifications such as those ... the outmoded use of passwords presents for BYOD, COPE, ... a unified biometric identity protocol. In ...
(Date:5/14/2015)... 2015  Verificient Technologies, Inc., a technology ... remote proctoring, announced a new alliance partnership ... creator of the Canvas Learning Management System ... will benefit from the seamless integration of ... a fully integrated multifactor biometrics behavioral application, ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
... It is estimated that 38 million people worldwide are ... are added each year. For scientists to design treatment ... essential to learn more about how the virus mutates ... by University of Victoria biomedical engineer Stephanie Willerth has ...
... lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates ... cancers, according to data presented at the 33rd Annual ... Full results were presented at the symposium during a ... CT. Reporters who cannot attend in person ...
... Today, the International Osteoporosis Foundation (IOF) and the World ... University of Sheffield, UK announced the launch of a FRAX ... freely accessible online calculator which has been developed by the ... risk of fragility fractures based on clinical risk factors, with ...
Cached Biology News:UVic biomedical engineer 'outsmarts' HIV 2Combination therapy reduced HER2-positive breast cancers 2WHO Fracture Risk Assessment Tool (FRAX) newly released for Singapore 2
... a complete, flexible system designed specifically ... as is frequently required in biological ... Instechs miniature Clark-style polarographic electrode. Measuring ... diameter (3.2 mm), it is ideal ...
... the family of human cullin genes (CUL-1, -2, -3, ... cdc53 gene. Cullin-3 is proposed to be a part ... with cyclin E and targets it for ubiquitination, which ... an activator of cdk2, which leads the cell to ...
... The MetaVue Imaging System is the cost-effective ... With commands tailored to common research imaging ... morphometric analysis and simple image analysis. ... control library means that MetaVue has the ...
... miRCURY Array LNA microarray slides for ... microarray slides incorporate Exiqons unique Locked Nucleic ... and excellent mismatch discrimination for short microRNA ... less than 1 g total RNA (no ...
Biology Products: